Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 4
2010 11
2011 10
2012 21
2013 36
2014 55
2015 66
2016 81
2017 89
2018 86
2019 87
2020 96
2021 115
2022 55
Text availability
Article attribute
Article type
Publication date

Search Results

709 results
Results by year
Filters applied: . Clear all
Page 1
The Microbiome in Cystic Fibrosis Pulmonary Disease.
Françoise A, Héry-Arnaud G. Françoise A, et al. Genes (Basel). 2020 May 11;11(5):536. doi: 10.3390/genes11050536. Genes (Basel). 2020. PMID: 32403302 Free PMC article. Review.
Cystic fibrosis (CF) is a genetic disease with mutational changes leading to profound dysbiosis, both pulmonary and intestinal, from a very young age. ...Animal models have also proved indispensable for validating microbiome pathophysiological hypotheses. Des
Cystic fibrosis (CF) is a genetic disease with mutational changes leading to profound dysbiosis, both pulmonary and intestinal
Interactions between the gut microbiome and host gene regulation in cystic fibrosis.
Dayama G, Priya S, Niccum DE, Khoruts A, Blekhman R. Dayama G, et al. Genome Med. 2020 Jan 28;12(1):12. doi: 10.1186/s13073-020-0710-2. Genome Med. 2020. PMID: 31992345 Free PMC article.
To investigate this, we characterized changes in the microbiome and host gene expression in the colonic mucosa of cystic fibrosis patients relative to healthy controls, and identified host gene-microbiome interactions in the colon of cystic f
To investigate this, we characterized changes in the microbiome and host gene expression in the colonic mucosa of cystic fi
Microbiology of Cystic Fibrosis Airway Disease.
Blanchard AC, Waters VJ. Blanchard AC, et al. Semin Respir Crit Care Med. 2019 Dec;40(6):727-736. doi: 10.1055/s-0039-1698464. Epub 2019 Dec 30. Semin Respir Crit Care Med. 2019. PMID: 31887768 Free PMC article. Review.
Although survival of individuals with cystic fibrosis (CF) has been continuously improving for the past 40 years, respiratory failure secondary to recurrent pulmonary infections remains the leading cause of mortality in this patient population. ...
Although survival of individuals with cystic fibrosis (CF) has been continuously improving for the past 40 years, respiratory …
Growth and Nutrition in Cystic Fibrosis.
Brownell JN, Bashaw H, Stallings VA. Brownell JN, et al. Semin Respir Crit Care Med. 2019 Dec;40(6):775-791. doi: 10.1055/s-0039-1696726. Epub 2019 Oct 28. Semin Respir Crit Care Med. 2019. PMID: 31659726 Review.
Optimal nutrition support has been integral in the management of cystic fibrosis (CF) since the disease was initially described. Nutritional status has a clear relationship with disease outcomes, and malnutrition in CF is typically a result of chronic negative energ …
Optimal nutrition support has been integral in the management of cystic fibrosis (CF) since the disease was initially describe …
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy.
Yi B, Dalpke AH, Boutin S. Yi B, et al. Front Cell Infect Microbiol. 2021 Mar 17;11:548613. doi: 10.3389/fcimb.2021.548613. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 33816324 Free PMC article. Review.
The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However, CFTR modulator therapy is still a life-long treatment, which is not able to correct the genetic defect and cure the disease. ...Whether an …
The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However …
The Microbiome in Cystic Fibrosis.
Huang YJ, LiPuma JJ. Huang YJ, et al. Clin Chest Med. 2016 Mar;37(1):59-67. doi: 10.1016/j.ccm.2015.10.003. Epub 2015 Dec 23. Clin Chest Med. 2016. PMID: 26857768 Free PMC article. Review.
Observations from studies during the last decade have changed the conventional view of cystic fibrosis (CF) microbiology, which has traditionally focused on a limited suite of opportunistic bacterial pathogens. It is now appreciated that CF airways typically harbor …
Observations from studies during the last decade have changed the conventional view of cystic fibrosis (CF) microbiology, whic …
Functional effects of the microbiota in chronic respiratory disease.
Budden KF, Shukla SD, Rehman SF, Bowerman KL, Keely S, Hugenholtz P, Armstrong-James DPH, Adcock IM, Chotirmall SH, Chung KF, Hansbro PM. Budden KF, et al. Lancet Respir Med. 2019 Oct;7(10):907-920. doi: 10.1016/S2213-2600(18)30510-1. Epub 2019 Apr 8. Lancet Respir Med. 2019. PMID: 30975495 Free article. Review.
The composition of the lung microbiome is increasingly well characterised, with changes in microbial diversity or abundance observed in association with several chronic respiratory diseases such as asthma, cystic fibrosis, bronchiectasis, and chronic obstruct …
The composition of the lung microbiome is increasingly well characterised, with changes in microbial diversity or abundance observed …
Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
Cribbs SK, Beck JM. Cribbs SK, et al. Transl Res. 2017 Jan;179:84-96. doi: 10.1016/j.trsl.2016.07.022. Epub 2016 Aug 4. Transl Res. 2017. PMID: 27559681 Review.
Complex microorganisms and microbial communities can now be identified in the distal airways in a variety of respiratory diseases, including cystic fibrosis (CF) and the posttransplantation lung. Although there are significant methodologic concerns about sampling th …
Complex microorganisms and microbial communities can now be identified in the distal airways in a variety of respiratory diseases, including …
How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?
Rogers GB, Bruce KD, Hoffman LR. Rogers GB, et al. Curr Opin Pulm Med. 2017 Nov;23(6):536-543. doi: 10.1097/MCP.0000000000000419. Curr Opin Pulm Med. 2017. PMID: 28786882 Free PMC article. Review.
PURPOSE OF REVIEW: Almost 15 years have now passed since bacterial community profiling techniques were first used to analyse respiratory samples from people with cystic fibrosis. Since then, many different analytical approaches have been used to try to better unders …
PURPOSE OF REVIEW: Almost 15 years have now passed since bacterial community profiling techniques were first used to analyse respiratory sam …
The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?
Héry-Arnaud G, Boutin S, Cuthbertson L, Elborn SJ, Tunney MM. Héry-Arnaud G, et al. J Cyst Fibros. 2019 Jan;18(1):13-21. doi: 10.1016/j.jcf.2018.11.003. Epub 2018 Nov 25. J Cyst Fibros. 2019. PMID: 30487080 Free article. Review.
The 15th European Cystic Fibrosis Society (ECFS) Basic Science pre-conference Symposium focused on the topic of the microbiome, asking the question "The lung and gut microbiome: what has to be considered for cystic fibrosis (CF)?" This re …
The 15th European Cystic Fibrosis Society (ECFS) Basic Science pre-conference Symposium focused on the topic of the microbi
709 results